by Cal Strode | Jan 28, 2026
This year marks the fourth consecutive time I’ve covered the Alliance for Regenerative Medicine’s (ARM) State of the Industry briefing for Signals, and I’ve enjoyed tracking how the cell and gene therapy sector has evolved in real time. In 2023 and 2024, the briefings...
by Cal Strode | Dec 1, 2025
To mark World AIDS Day, I revisited the rapidly shifting HIV cure research landscape, checking in on International AIDS Society (IAS) 2025 to see how things have evolved since 2021, when I last covered progress for Signals. Curative approaches are starting to move on...
by CCRM Australia | Oct 1, 2025
Silvio Tiziani, MBA, GAICD, is the CEO of CCRM Australia, leading efforts to bridge the gap between research and industry in regenerative medicine. With extensive experience across academia, health, and industry, he has successfully developed strategic partnerships,...
by Lyla El-Fayomi | Jul 17, 2025
The volume of clinical updates I encounter every month is steadily but very noticeably growing month over month! There are lots to get through, so in this rapid-fire edition of RMNU🔬, you’ll find short summaries on all the biggest headlines of the summer’s first half....
by Krystal Jacques | May 29, 2025
Imagine a one-and-done treatment for stroke using the regenerative capacity of your brain. Tianhao Chen, Dr. Cindi Morshead’s lab, and Dr. Hani E. Naguib’s lab have developed a biodegradable electrode that can electrically stimulate neural precursor cells (NPCs). This...
Comments